Europe Conjugate Vaccine Market
Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached with a protein tenhance immunogenicity and protect against invasive diseases. Europe is a market with stable growth for conjugate vaccines. The conjugate vaccine market in Europe is expected texpand at a CAGR of 3.6% leading ta revenue of USD 8.94 Bn by 2023. By volume, it is anticipated treach 504.46 Million units by 2023, expanding at a CAGR of 3.7%.
Get Sample Copy of Report Here: www.marketresearchstore.com/report/europe-conjugate-vaccine-market-2018-2023-313839#RequestSample
The U.K. was the first country tintroduce MenB-4C inttheir National Infant Immunization Program (2015). In all EU/EEA countries, Hib vaccination has been part of the immunization programs, since 2010, and high coverage has been sustained.
Based on disease indication, the market is segmented intpneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others.
Based on end user, the market is segmented intpediatric and adult.
Based on countries, the Europe market is divided intEU5 and Rest of EU.
Do Inquiry Before Purchasing Report Here: www.marketresearchstore.com/report/europe-conjugate-vaccine-market-2018-2023-313839#InquiryForBuying
Key growth factors:
The European market will not display any extraordinary growth but average figures. Key growth factors include increasing emphasis on and availability of funds for research and development. Moreover, advancements in medical science, awareness about the availability of a higher number of vaccines for diseases will drive the growth of this market. Increasing vaccination programs by government, their initiatives, and increase in research and development activities will result in the growth of this market.
Threats and key players:
The Europe conjugate vaccine market is expected tgrow at a steady pace. The scope for significant growth is limited. Vaccine shortages are a major problem which will hinder the growth of the market. The shortage of vaccines affecting some EU/EEA Member States had direct effects on the delivery of national vaccination programmes. Since 2015, nine EU/EEA member states had tadjust their immunization policies.
Major conjugate vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.
Visit Complete Report with TOC Here: www.marketresearchstore.com/report/europe-conjugate-vaccine-market-2018-2023-313839#tableOfContent
What’s covered in the report?
Overview of the Europe conjugate vaccine market
Market drivers and challenges in the Europe conjugate vaccine market
Market trends in the Europe conjugate vaccine market
Historical, current and forecasted market size data for Europe based on disease indication (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) – by revenue and by volume
Historical, current and forecasted market size data for Europe based on end user (pediatric and adult conjugate vaccines) – by revenue and by volume
Historical, current and forecasted market size data of conjugate vaccines based on countries (EU5, Rest of EU) – by revenue and by volume
Historical, current and forecasted market size data for country-wise segments – by revenue and by volume
Analysis of the competitive landscape and profiles of major companies operating in the European market
Understand the demand for conjugate vaccines tdetermine the viability of the market
Understand the country-specific market size and observations for each segment
Develop strategies based on the drivers, trends and highlights for each of the segments
Evaluate the value chain tdetermine the workflow and tget an idea of the current position where you are placed
Recognize the key competitors of this market and respond accordingly
Identify the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth
Define the competitive positioning by comparing the products and services with the key players in the market